1,233 results on '"Alvaro, Domenico"'
Search Results
2. Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance
3. Publisher Correction: A postnatal network of co-hepato/pancreatic stem/progenitors in the biliary trees of pigs and humans
4. A postnatal network of co-hepato/pancreatic stem/progenitors in the biliary trees of pigs and humans
5. Intrahepatic cholangiocarcinoma: Evolving strategies in management and treatment
6. Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis
7. Biliary stem cells in health and cholangiopathies and cholangiocarcinoma
8. Artificial Intelligence and liver: Opportunities and barriers
9. A global research priority agenda to advance public health responses to fatty liver disease
10. EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma
11. Secretin alleviates biliary and liver injury during late-stage primary biliary cholangitis via restoration of secretory processes
12. Human duodenal submucosal glands contain a defined stem/progenitor subpopulation with liver-specific regenerative potential
13. Therapeutic effects of dexamethasone-loaded hyaluronan nanogels in the experimental cholestasis
14. THU-101 Non-invasive tests for ruling out high-risk esophageal varices in patients with primary biliary cholangitis based on the cholestasis degree
15. LBP-038 Expanding knowledge regarding real-world treatment of patients with primary biliary cholangitis with obeticholic acid from the Italian RECAPITULATE cohort
16. FRI-481 Analysis of HBV DNA integration in patients with intrahepatic cholangiocarcinomas and overt or occult HBV infection
17. THU-093 Biochemical response and liver stiffness variation over time predict liver-related events in patients with primary biliary cholangitis treated with Obeticholic acid
18. Oleuropein, a Component of Extra Virgin Olive Oil, Improves Liver Steatosis and Lobular Inflammation by Lipopolysaccharides–TLR4 Axis Downregulation
19. Development and validation of a scoring system to predict response to obeticholic acid in primary biliary cholangitis.
20. Transjugular Intrahepatic Portosystemic Shunt as a Bridge to Abdominal Surgery in Cirrhosis
21. Opioid-Induced Constipation in Real-World Practice: A Physician Survey, 1 Year Later
22. Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis
23. Primary biliary cholangitis: perception and expectation of illness
24. Patch grafting of organoids of stem/progenitors into solid organs can correct genetic-based disease states
25. Platelet and immune signature associated with a rapid response to the BNT162b2 mRNA COVID‐19 vaccine
26. The application of artificial intelligence in hepatology: A systematic review
27. Acute diverticulitis: beyond the diagnosis: predictive role of CT in assessing risk of recurrence and clinical implications in non-operative management of acute diverticulitis.
28. Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis
29. Patch grafting, strategies for transplantation of organoids into solid organs such as liver
30. Changes in digestive cancer diagnosis during the SARS-CoV-2 pandemic in Italy: A nationwide survey
31. Real-world experience with obeticholic acid in patients with primary biliary cholangitis
32. Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles
33. Vav1 Sustains the In Vitro Differentiation of Normal and Tumor Precursors to Insulin Producing Cells Induced by all-Trans Retinoic Acid (ATRA)
34. Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part II: Treatment
35. Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis
36. Italian Clinical Practice Guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging
37. Impact of SARS-CoV-2 vaccination on FcγRIIIA/CD16 dynamics in Natural Killer cells: relevance for antibody-dependent functions
38. Corrigendum to “EASL-ILCA clinical practice guidelines on the management of intrahepatic cholangiocarcinoma” [J Hepatol (79) (2023) 181–208]
39. What to Do and What Not to Do in the Management of Opioid-Induced Constipation: A Choosing Wisely Report
40. Neutrophil Cathepsin G and Thrombosis in COVID-19.
41. Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells
42. Cholangiocarcinoma 2020: the next horizon in mechanisms and management
43. CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cells
44. Epidemiology of primary biliary cholangitis in Italy: Evidence from a real-world database
45. Knockout of secretin receptor reduces biliary damage and liver fibrosis in Mdr2−/− mice by diminishing senescence of cholangiocytes
46. The Secretin/Secretin Receptor Axis Modulates Ductular Reaction and Liver Fibrosis through Changes in Transforming Growth Factor-β1–Mediated Biliary Senescence
47. Artificial Intelligence and liver: Opportunities and barriers
48. Intrahepatic cholangiocarcinoma: Evolving strategies in management and treatment
49. Cell transplantation-based regenerative medicine in liver diseases
50. Estrogen Regulation of Cholangiocyte Proliferation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.